Transforming Growth Factor Activity Is a Key Determinant for the Effect of Estradiol on Fatty Streak Deposit in Hypercholesterolemic Mice

Autor: Barbara Garmy-Susini, Cédric Filipe, Bertrand Calippe, Alexia Schambourg, François Tercé, Pierre Gourdy, Victorine Douin-Echinard, Jean-François Arnal, Francis Bayard
Přispěvatelé: Institut de médecine moléculaire de Rangueil (I2MR), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-IFR150-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de diabétologie, Pôle Cardio-Vasculaire et Métabolique, CHU Toulouse [Toulouse]-Hôpital de Rangueil, CHU Toulouse [Toulouse], Departement /u563 : Lipoproteines et Mediateurs Lipidiques, Centre de Physiopathologie Toulouse Purpan (CPTP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Simon, Marie Francoise, Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées- Institut Fédératif de Recherche Bio-médicale Institution (IFR150)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service Diabétologie [CHU Toulouse], Pôle Cardiovasculaire et Métabolique [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)
Rok vydání: 2007
Předmět:
MESH: Interleukin-12
MESH: Signal Transduction
MESH: Interleukin-10
medicine.medical_treatment
MESH: Mice
Knockout

MESH: Drug Implants
MESH: Antibodies
Monoclonal

MESH: Atherosclerosis
Mice
MESH: Transforming Growth Factor beta1
0302 clinical medicine
MESH: Animals
MESH: Bone Marrow Transplantation
Aorta
Bone Marrow Transplantation
Drug Implants
Mice
Knockout

0303 health sciences
Estradiol
Antibodies
Monoclonal

MESH: Hypercholesterolemia
Interleukin
MESH: Aorta
MESH: Apolipoproteins E
Interleukin-12
Interleukin-10
Cytokine
030220 oncology & carcinogenesis
Disease Progression
Female
MESH: Disease Progression
MESH: Estradiol
medicine.symptom
Cardiology and Cardiovascular Medicine
MESH: Whole-Body Irradiation
Whole-Body Irradiation
Signal Transduction
medicine.medical_specialty
MESH: Interferon-gamma
medicine.drug_class
Ratón
Ovariectomy
Hypercholesterolemia
MESH: Ovariectomy
Inflammation
Biology
Proinflammatory cytokine
Transforming Growth Factor beta1
Interferon-gamma
03 medical and health sciences
Apolipoproteins E
MESH: Mice
Inbred C57BL

Internal medicine
medicine
Animals
MESH: Smad3 Protein
Smad3 Protein
MESH: Mice
030304 developmental biology
Fatty streak
Atherosclerosis
Mice
Inbred C57BL

Disease Models
Animal

Endocrinology
Receptors
LDL

MESH: Receptors
LDL

Estrogen
MESH: Disease Models
Animal

MESH: Female
Transforming growth factor
Zdroj: Arteriosclerosis, Thrombosis, and Vascular Biology
Arteriosclerosis, Thrombosis, and Vascular Biology, American Heart Association, 2007, 27 (10), pp.2214-21. ⟨10.1161/ATVBAHA.107.150300⟩
Arteriosclerosis, Thrombosis, and Vascular Biology, 2007, 27 (10), pp.2214-21. ⟨10.1161/ATVBAHA.107.150300⟩
ISSN: 1524-4636
1079-5642
DOI: 10.1161/atvbaha.107.150300
Popis: Objective— Whereas estradiol prevents fatty streak deposit in immunocompetent apoE −/− or LDLr −/− mice, it is totally ineffective in immunodeficient mice, underlining the key role of immunoinflammation in this effect. In the present work, the role of several major pro- and antiinflammatory cytokines involved in the atheromatous process was evaluated in the effect of estradiol on fatty streak constitution. Methods and Results— The preventive effect of estradiol was fully maintained in LDLr −/− mice grafted with bone marrow from either IFN-γ or interleukin (IL)-12–deficient mice, showing that this beneficial effect was not mediated through a specific decrease in the production of these 2 proinflammatory cytokines. Furthermore, IL-10 −/− apoE −/− mice remained protected by estradiol, excluding a significant contribution of this antiinflammatory cytokine. In contrast, the protective effect of estradiol was (1) associated with enhanced aortic expression of TGF-β1 in apoE −/− mice during early steps of atherogenesis; (2) abolished and even reversed in apoE −/− mice administered with a neutralizing anti–TGF-β antibody; (3) abolished in LDLr −/− mice grafted with bone marrow from Smad3-deficient mice. Conclusions— The status of the TGF-β pathway crucially determines the antiatherogenic effect of estradiol in hypercholesterolemic mice, whereas neither IFN-γ, IL-12, nor IL-10 are specifically involved in this protection.
Databáze: OpenAIRE